Word

CLINIMACS CELL FACTORY

Status

Registered

Status Code

700

Status Date

Tuesday, January 12, 2021

Serial Number

79279344

Registration Number

6242135

Registration Date

Tuesday, January 12, 2021

Mark Type

4000

Filing Date

Thursday, October 10, 2019

Published for Opposition

Tuesday, October 27, 2020

Trademark Owner History

Miltenyi Biotec B.V. & Co. KG - Original Registrant
Miltenyi Biotec GmbH - Original Applicant

Classifications

1 Chemicals and/or biological preparations for use in industry and science; diagnostic preparations for scientific or research use including medical laboratory diagnosis; chemicals, biological and biochemical preparations for use in separation processes for biological materials, in particular nucleic acid for laboratory use; reagents for scientific and research use, namely, reagents for cell separation, labelling reagents; chemicals for scientific use and for use in medical laboratories for use in separation processes for biological materials; molecules of microorganisms including viruses, bacteria, fungi, in particular proteins, peptides, and protein and peptide pools, oligosaccharides, lipids, hybridization solutions, chemical preparations for cleaning purposes, cDNA clones, all for use in industry and science; reagents, chemical and/or biological media, materials and components for preparing media, all of the aforesaid for industrial and scientific purposes and for use in medical laboratories; reagents for use in science and/or industry for processing, separating, isolating, enriching, expanding, differentiating, depleting, detecting, screening, analyzing and tallying material, in particular chemicals and biological material, reagents featuring magnetic beads, antibody reagents; buffer solutions and reagents for use with laboratory apparatus, in particular separation apparatus, analyzers, reactors, cell processing apparatus and imaging apparatus; reagents for use in science and/or industry for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; chemical reagents and preparations for use in the manufacture of medicines; culture media, cell culture media, freezing media for in vivo scientific use; reagents other than for medical purposes for use in biotechnology, in biological processing operations and in the biotechnology industry, and the manufacture of medicine; chemicals and biological preparations for use in industry and science; diagnostic preparations for scientific or research use; chemical and/or biological substances and mixtures for industrial and scientific applications in preparing media; culture media for scientific use, namely, biology, microbiology, and for use in the biotechnical industry and in medical research; chemical preparations for use in pharmaceutical and medical science; reagents for clinical and non-clinical laboratory use, in particular cytokines and antibodies

5 Pharmaceutical and medical preparations for the treatment of cancer, heart disease, diabetes, and blood disorders; biochemical, in particular immunological preparations in the nature of immunostimulants, vaccines, and cells for medical and pharmaceutical purposes; absorbents for therapeutic purposes in the field of extracorporeal plasma treatment, namely, peptide adsorbents; pharmaceutical preparations and pharmaceuticals in the field of extracorporeal plasma therapy, namely, blood purifying preparations, extracorporeal plasma therapy solutions, physiological saline solutions, glycine solutions, PBS solutions, preparations for extending blood coagulation time, heparin solutions; biochemical preparations for medical and pharmaceutical purposes in the field of extracorporeal plasma, in particular immunological preparations for the prevention and treatment of diseases and disorders of the immune system; reagents and cell growth media, and substances and components for the preparation of cell growth media, all being for medical purposes; reagents for processing, separating, isolating, enriching, depleting, detecting, expanding, differentiating, screening, analyzing and tallying biological material, reagents containing magnetic beads, and antibody reagents, all for medical purposes; buffer solutions and reagents for use with medical apparatus, in particular separation apparatus, analyzers, reactors, cell processing apparatus and imaging apparatus; reagents for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof, all being for medical purposes; reagents for medical use and preparations for medical purposes for the treatment of cancer, heart disease, diabetes and blood disorders; culture media for cultivating human cells and human tissue, cell culture media for cultivating human cells and human tissue, freezing media for the cryopreservation of human cells and human tissue, contrast agents and contract agents for in vivo imaging, all of the aforesaid goods for medical, pharmaceutical purposes; cellular medicines and pharmaceutical treatments for the treatment of cancer, heart disease, diabetes and blood disorders; chemical, biochemical and biological preparations for pharmaceutical and medical purposes for the treatment of cancer, heart disease, diabetes, and blood disorders; molecules of microorganisms including viruses, bacteria, fungi, in particular proteins, peptides, and protein and peptide pools, all for medical purposes; freezing preparations for medical purposes for the cryopreservation of human cells and human tissues; diagnostic preparations and substances for medical purposes; media for cell culture for cultivating human cells and human tissue; media for bacteriological cultures for medical purposes; cell cultures, fungal cultures and virus cultures, all for medical purposes; pharmaceuticals for cellular therapy; reagents for medical use, in particular cytokines and antibodies

9 Scientific apparatus and instruments for magnetic cell separation for use in clinical and non-clinical laboratories; apparatus and instruments for use in clinical and non-clinical laboratories, in particular an automated system for processing cells; test tube sets for scientific purposes; chromatography columns for laboratory use; laboratory centrifuges; laboratory incubators; laboratory bioreactors; component and replacement parts for all the mentioned goods; scientific, electric and electronic apparatus and instruments for separating biological material for scientific use, in particular for separating cells and biological macro-molecules, in particular proteins, nucleic acids; scientific, electric and electronic apparatus and instruments for conducting enzymatic reactions for scientific use; liquid and gas analyzers, and recorded control software, laboratory pipetting stations and laboratory sample carrier plates therefor; scientific apparatus and instruments for magnetically sorting biological material, and computer hardware and recorded computer operating software therefor; cell separation and cell processing apparatus for laboratory use; cytometers; microchips and data carriers containing recorded software for use with gene detecting apparatus, namely, for indicating pathological changes; microchips in the form of coated glass slides or plastic materials; microchips and testing instruments for the diagnostic detection of gene expression profiles indicative of pathological changes for scientific research use; electric and electronic apparatus and instruments for cell separation and for cell processing, for use in clinical and non-clinical laboratories; sacks, pouches, bags and films specially adapted for the holding of cell culture and biotechnological preparations for scientific or laboratory use, in particular for cryopreservation; component and replacement parts for all the mentioned goods

10 Medical apparatus and instruments, namely, apparatus and instruments for magnetic cell separation for medical purposes; apparatus and instruments for medical use, in particular an automated system for processing cells; blood tube sets for medical purposes; analysis columns for medical purposes, for blood analysis; incubation units for medical purposes; bio-reactors for medical purposes for cell culturing; component and replacement parts for the aforesaid goods; medical apparatus for extracorporeal immunoadsorption; medical apparatus and equipment for extracorporeal plasma therapy and component and replacement parts and fittings therefor, in particular sterile bottles, filters, membrane filters, cannulae and tubes for medical purposes, being replaceable parts; chromatography columns for medical use, in particular adsorption columns and cartridges for use in extra-corporal plasma therapy; medical apparatus and equipment for separating plasma and component and replacement parts and fittings therefor, in particular sterile bottles, filters, membrane filters and tubes for medical purposes, being replaceable parts; extracorporeal plasma therapy systems for medical purposes comprised of units for separating plasma, plastic containers and bags for plasma for medical purposes, plasma filter and collecting tubes, sterile filters for medical purposes, control units, microprocessors, pumps, monitors, pH detectors, air detectors and photodetectors, optical detectors; medical apparatus in the nature of absorber cartridges and columns for use in extracorporeal plasma therapy; medical apparatus and equipment for separating plasma; apparatus for magnetic cell separation for medical purposes; sacks, pouches, bags, foils, hoses and connectors adapted for medical use, in particular for cryopreservation of human cells and human tissues; chromatography columns for medical use, in particular immune adsorption columns for ex-vivo application in therapy; medical measuring apparatus and instruments, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; component and replacement parts for the aforesaid goods

42 Scientific and technological services, namely, research and design in the field of computer hardware and software for the analysis of biological and biochemical materials ; industrial analysis and research services; design and development of computer hardware and computer software, all of the aforesaid services for and in connection with the analysis of biological material, in particular cell material for biological and medical research and therapy; scientific services relating to the isolation and cultivation of cell materials for biological and medical research and therapy; design and development of laboratory processes for manufacturing cell products; design and development of computer hardware and software, in connection with manufacturing cell preparations, selecting, stimulating, activating cells for medical, scientific, pharmaceutical or biotechnological purposes, and products necessary therefor; development of software in the field of molecular biology; biotechnological laboratory services, in particular in connection with manufacturing cell therapy products, cell preparations, cellular medicines, selecting, stimulating, activating cells, and manufacturing kits or reagents; chemistry, biology and molecular biology laboratory services; design and development of manufacturing processes for medical cell preparations

44 Medical and pharmaceutical compounding services; medical, pharmaceutical laboratory services, in particular providing medical and pharmaceutical consultation in connection with manufacturing cell therapy products, cell preparations, cellular medicines, selecting, stimulating, activating cells, and manufacturing kits or reagents; medical services, in particular in the field of extracorporeal plasma therapy; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

"CELL FACTORY"

Trademark Events

May 11, 2021

Final Decision Transaction Processed By Ib

Apr 19, 2021

Final Disposition Notice Sent To Ib

Apr 19, 2021

Final Disposition Processed

Apr 12, 2021

Final Disposition Notice Created, To Be Sent To Ib

Jan 12, 2021

Registered-Principal Register

Oct 27, 2020

Official Gazette Publication Confirmation E-Mailed

Oct 27, 2020

Published For Opposition

Oct 25, 2020

Notification Processed By Ib

Oct 7, 2020

Notification Of Possible Opposition Sent To Ib

Oct 7, 2020

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Oct 7, 2020

Notification Of Notice Of Publication E-Mailed

Sep 23, 2020

Law Office Publication Review Completed

Sep 18, 2020

Change Of Owner Received From Ib

Sep 16, 2020

Assigned To Lie

Sep 3, 2020

Approved For Pub - Principal Register

Sep 3, 2020

Examiner's Amendment Entered

Sep 3, 2020

Notification Of Examiners Amendment E-Mailed

Sep 3, 2020

Examiners Amendment E-Mailed

Sep 3, 2020

Examiners Amendment -Written

Sep 3, 2020

Previous Allowance Count Withdrawn

Aug 29, 2020

Withdrawn From Issue - Senior Attorney Request

Jul 31, 2020

Notification Processed By Ib

Jul 28, 2020

Official Gazette Publication Confirmation E-Mailed

Jul 28, 2020

Published For Opposition

Jul 15, 2020

Notification Of Possible Opposition Sent To Ib

Jul 15, 2020

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jul 8, 2020

Notification Of Notice Of Publication E-Mailed

Jun 22, 2020

Approved For Pub - Principal Register

Jun 6, 2020

Examiner's Amendment Entered

Jun 6, 2020

Notification Of Examiners Amendment E-Mailed

Jun 6, 2020

Examiners Amendment E-Mailed

Jun 6, 2020

Examiners Amendment -Written

May 27, 2020

Notification Of Non-Final Action E-Mailed

May 27, 2020

Non-Final Action E-Mailed

May 27, 2020

Non-Final Action Written

May 7, 2020

Teas/Email Correspondence Entered

May 6, 2020

Correspondence Received In Law Office

May 6, 2020

Teas Response To Office Action Received

Apr 10, 2020

Refusal Processed By Ib

Mar 24, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Mar 24, 2020

Refusal Processed By Mpu

Mar 4, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Mar 3, 2020

Non-Final Action Written

Feb 29, 2020

Application Filing Receipt Mailed

Feb 25, 2020

Assigned To Examiner

Feb 25, 2020

New Application Office Supplied Data Entered In Tram

Feb 20, 2020

Sn Assigned For Sect 66a Appl From Ib